Portfolio Holdings Detail for ISIN IE00BDZVHG35
Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /var/www/liquidata/show_ticker_holding_ETFs.php on line 67
Stock Name / Fund iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Issuer Blackrock

ETF Ticker BTEE(USD) LSE
ETF Ticker BTEE.L(GBP) LSE

Holdings detail for IRON

Stock Name	Ironveld Plc
Ticker	IRON(GBX) LSE
TYPE	Common Stock
Country	UK
ISIN	GB0030426455
LEI	2138004LU52LQBNXG604

Show aggregate IRON holdings

News associated with IRON

Disc Medicine (NASDAQ:IRON) Price Target Raised to $90.00: Disc Medicine (NASDAQ:IRON – Get Free Report) had its price objective raised by Morgan Stanley from $85.00 to $90.00 in a research report issued on Monday,Benzinga reports. The firm currently has an “overweight” rating on the stock. Morgan Stanley’s price objective would indicate a potential upside of 54.69% from the company’s previous close. IRON has […] - 2025-08-20 02:46:48
Disc Medicine, Inc. (NASDAQ:IRON) Shares Bought by Arizona State Retirement System: Arizona State Retirement System grew its holdings in shares of Disc Medicine, Inc. (NASDAQ:IRON – Free Report) by 12.5% in the first quarter, HoldingsChannel reports. The fund owned 5,315 shares of the company’s stock after buying an additional 590 shares during the period. Arizona State Retirement System’s holdings in Disc Medicine were worth $264,000 as […] - 2025-07-23 05:44:47
Arizona State Retirement System Acquires 590 Shares of Disc Medicine, Inc. (NASDAQ:IRON): Arizona State Retirement System lifted its holdings in shares of Disc Medicine, Inc. (NASDAQ:IRON – Free Report) by 12.5% in the first quarter, Holdings Channel.com reports. The institutional investor owned 5,315 shares of the company’s stock after acquiring an additional 590 shares during the period. Arizona State Retirement System’s holdings in Disc Medicine were worth […] - 2025-07-23 05:08:54
Disc Medicine To Seek FDA Approval For Bitopertin In EPP, A Painful Sunlight Sensitivity Disorder: (RTTNews) - Disc Medicine Inc. (IRON) is planning to submit a New Drug Application for its investigational oral drug Bitopertin in Erythropoietic Protoporphyria in October of this year. - 2025-07-22 08:18:48
Disc Medicine (NASDAQ:IRON) Earns Buy Rating from HC Wainwright: HC Wainwright reaffirmed their buy rating on shares of Disc Medicine (NASDAQ:IRON – Free Report) in a report issued on Thursday morning,Benzinga reports. The firm currently has a $118.00 price target on the stock. Several other equities research analysts have also recently commented on IRON. Morgan Stanley reaffirmed an “overweight” rating and issued a $85.00 […] - 2025-07-04 04:59:48
Disc Medicine (NASDAQ:IRON) Coverage Initiated by Analysts at Raymond James: Raymond James assumed coverage on shares of Disc Medicine (NASDAQ:IRON – Free Report) in a research note published on Wednesday morning, MarketBeat.com reports. The brokerage issued a strong-buy rating and a $89.00 price target on the stock. A number of other research firms have also issued reports on IRON. Scotiabank raised their price target on […] - 2025-06-12 04:32:50
Disc Medicine, Inc. (NASDAQ:IRON) Given Consensus Rating of “Buy” by Brokerages: Shares of Disc Medicine, Inc. (NASDAQ:IRON – Get Free Report) have earned a consensus recommendation of “Buy” from the eleven brokerages that are covering the firm, MarketBeat Ratings reports. Ten equities research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. The average 1-year […] - 2025-06-03 02:36:48
Nuveen Asset Management LLC Decreases Position in Disc Medicine, Inc. (NASDAQ:IRON): Nuveen Asset Management LLC decreased its stake in Disc Medicine, Inc. (NASDAQ:IRON – Free Report) by 47.1% in the 4th quarter, Holdings Channel.com reports. The institutional investor owned 50,121 shares of the company’s stock after selling 44,683 shares during the quarter. Nuveen Asset Management LLC’s holdings in Disc Medicine were worth $3,178,000 as of its […] - 2025-06-02 04:58:47
Disc Medicine, Inc. (NASDAQ:IRON) Shares Purchased by ProShare Advisors LLC: ProShare Advisors LLC lifted its stake in Disc Medicine, Inc. (NASDAQ:IRON – Free Report) by 26.5% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 6,966 shares of the company’s stock after acquiring an additional 1,458 shares during the period. ProShare […] - 2025-05-28 04:54:55
Deutsche Bank AG Purchases 6,933 Shares of Disc Medicine, Inc. (NASDAQ:IRON): Deutsche Bank AG boosted its position in shares of Disc Medicine, Inc. (NASDAQ:IRON – Free Report) by 75.7% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 16,093 shares of the company’s stock after purchasing an additional 6,933 shares during the period. Deutsche Bank AG’s […] - 2025-05-27 05:16:55
Schonfeld Strategic Advisors LLC Has $311,000 Stock Position in Disc Medicine, Inc. (NASDAQ:IRON): Schonfeld Strategic Advisors LLC decreased its holdings in shares of Disc Medicine, Inc. (NASDAQ:IRON – Free Report) by 7.2% during the 4th quarter, HoldingsChannel.com reports. The firm owned 4,900 shares of the company’s stock after selling 381 shares during the period. Schonfeld Strategic Advisors LLC’s holdings in Disc Medicine were worth $311,000 as of its […] - 2025-05-13 05:38:52
Disc Medicine, Inc. (NASDAQ:IRON) Receives $93.80 Average Target Price from Analysts: Disc Medicine, Inc. (NASDAQ:IRON – Get Free Report) has received a consensus recommendation of “Buy” from the eleven research firms that are covering the company, MarketBeat reports. Ten equities research analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. The average 12 month price […] - 2025-05-12 02:40:44
Sterling Capital Management LLC Boosts Stake in Disc Medicine, Inc. (NASDAQ:IRON): Sterling Capital Management LLC boosted its holdings in Disc Medicine, Inc. (NASDAQ:IRON – Free Report) by 798.4% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 566 shares of the company’s stock after acquiring an additional 503 shares during the quarter. Sterling Capital Management LLC’s […] - 2025-04-25 06:10:48
Raymond James Financial Inc. Makes New Investment in Disc Medicine, Inc. (NASDAQ:IRON): Raymond James Financial Inc. acquired a new stake in shares of Disc Medicine, Inc. (NASDAQ:IRON – Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 88,002 shares of the company’s stock, valued at approximately $5,579,000. Raymond James Financial Inc. owned 0.30% […] - 2025-04-25 05:28:48
Renaissance Technologies LLC Takes Position in Disc Medicine, Inc. (NASDAQ:IRON): Renaissance Technologies LLC purchased a new position in shares of Disc Medicine, Inc. (NASDAQ:IRON – Free Report) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 86,420 shares of the company’s stock, valued at approximately $5,479,000. Several other large investors have also recently made changes […] - 2025-04-21 05:52:45
Intech Investment Management LLC Increases Stock Position in Disc Medicine, Inc. (NASDAQ:IRON): Intech Investment Management LLC boosted its holdings in Disc Medicine, Inc. (NASDAQ:IRON – Free Report) by 69.8% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 7,890 shares of the company’s stock after purchasing an additional 3,243 shares during the […] - 2025-03-25 06:29:03
Disc Medicine, Inc. (NASDAQ:IRON) Director Sells $2,142,217.12 in Stock: Disc Medicine, Inc. (NASDAQ:IRON – Get Free Report) Director Mona Ashiya sold 39,656 shares of the business’s stock in a transaction that occurred on Wednesday, March 19th. The shares were sold at an average price of $54.02, for a total value of $2,142,217.12. Following the sale, the director now owns 188,981 shares of the company’s […] - 2025-03-24 06:04:53
Disc Medicine, Inc. (NASDAQ:IRON) Director Mona Ashiya Sells 10,011 Shares: Disc Medicine, Inc. (NASDAQ:IRON – Get Free Report) Director Mona Ashiya sold 10,011 shares of the company’s stock in a transaction that occurred on Friday, March 21st. The stock was sold at an average price of $54.00, for a total transaction of $540,594.00. Following the completion of the sale, the director now directly owns 187,297 […] - 2025-03-24 06:04:53
Disc Medicine (NASDAQ:IRON) Stock Price Expected to Rise, Cantor Fitzgerald Analyst Says: Disc Medicine (NASDAQ:IRON – Get Free Report) had its target price increased by analysts at Cantor Fitzgerald from $99.00 to $132.00 in a note issued to investors on Tuesday, MarketBeat.com reports. The firm currently has an “overweight” rating on the stock. Cantor Fitzgerald’s price objective would suggest a potential upside of 145.63% from the stock’s […] - 2025-03-20 06:28:53
Disc Medicine, Inc. (NASDAQ:IRON) Shares Bought by Victory Capital Management Inc.: Victory Capital Management Inc. raised its holdings in Disc Medicine, Inc. (NASDAQ:IRON – Free Report) by 7.4% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 236,244 shares of the company’s stock after acquiring an additional 16,230 shares during the quarter. Victory Capital Management […] - 2025-03-13 06:32:54
Bleakley Financial Group LLC Acquires Shares of 7,667 Disc Medicine, Inc. (NASDAQ:IRON): Bleakley Financial Group LLC acquired a new stake in shares of Disc Medicine, Inc. (NASDAQ:IRON – Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 7,667 shares of the company’s stock, valued at approximately $486,000. Several other institutional investors have also […] - 2025-02-11 06:46:53

iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) IRON holdings

Date	Number of IRON Shares Held	Base Market Value of IRON Shares	Local Market Value of IRON Shares	Change in IRON Shares Held	Change in IRON Base Value	Current Price per IRON Share Held	Previous Price per IRON Share Held
2025-12-16 (Tuesday)	25,902	USD 2,369,256	USD 2,369,256	-58	USD -19,064	USD 91.47	USD 92
2025-12-15 (Monday)	25,960	USD 2,388,320	USD 2,388,320	116	USD 14,549	USD 92	USD 91.85
2025-12-12 (Friday)	25,844	USD 2,373,771	USD 2,373,771	0	USD -45,227	USD 91.85	USD 93.6
2025-12-11 (Thursday)	25,844	USD 2,418,998	USD 2,418,998	116	USD 30,153	USD 93.6	USD 92.85
2025-12-10 (Wednesday)	25,728	USD 2,388,845	USD 2,388,845	0	USD 29,073	USD 92.85	USD 91.72
2025-12-09 (Tuesday)	25,728	USD 2,359,772	USD 2,359,772	0	USD -13,379	USD 91.72	USD 92.24
2025-12-08 (Monday)	25,728	USD 2,373,151	USD 2,373,151	0	USD -26,242	USD 92.24	USD 93.26
2025-12-05 (Friday)	25,728	USD 2,399,393	USD 2,399,393	0	USD -13,636	USD 93.26	USD 93.79
2025-12-04 (Thursday)	25,728	USD 2,413,029	USD 2,413,029	1,160	USD 143,437	USD 93.79	USD 92.38
2025-12-03 (Wednesday)	24,568	USD 2,269,592	USD 2,269,592	0	USD 65,351	USD 92.38	USD 89.72
2025-12-02 (Tuesday)	24,568	USD 2,204,241	USD 2,204,241	870	USD 31,371	USD 89.72	USD 91.69
2025-12-01 (Monday)	23,698	USD 2,172,870	USD 2,172,870	0	USD -39,575	USD 91.69	USD 93.36

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of IRON by Blackrock for IE00BDZVHG35

Show aggregate share trades of IRON

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-12-16 SELL -58 91.780 90.165 90.327 GBX -5,239 60.54 Loss of -1,727 on sale
2025-12-15 BUY 116 92.530 90.010 90.262 GBX 10,470 60.39
2025-12-11 BUY 116 94.450 90.400 90.805 GBX 10,533 60.09
2025-12-04 BUY 1,160 93.790* 59.28
2025-12-02 BUY 870 93.325 89.440 89.829 GBX 78,151 58.97
2025-11-28 BUY 58 94.520 92.840 93.008 GBX 5,394 58.63
2025-11-26 BUY 174 94.130 91.730 91.970 GBX 16,003 58.28
2025-11-26 BUY 174 94.130 91.730 91.970 GBX 16,003 58.28
2025-11-25 BUY 290 95.135 91.660 92.008 GBX 26,682 58.11
2025-11-24 BUY 58 97.115 93.690 94.033 GBX 5,454 57.92
2025-11-20 SELL -232 94.400 89.800 90.260 GBX -20,940 57.58 Loss of -7,583 on sale
2025-11-19 BUY 58 92.680 89.900 90.178 GBX 5,230 57.40
2025-11-18 BUY 348 90.680 87.560 87.872 GBX 30,579 57.24
2025-11-17 BUY 116 92.655 88.230 88.673 GBX 10,286 57.07
2025-11-14 BUY 58 90.850 86.930 87.322 GBX 5,065 56.89
2025-11-12 BUY 58 87.605 85.320 85.549 GBX 4,962 56.58
2025-11-10 BUY 58 85.570 82.235 82.569 GBX 4,789 56.27
2025-11-06 BUY 58 90.385 86.200 86.618 GBX 5,024 55.96
2025-11-04 BUY 58 87.125 83.010 83.422 GBX 4,838 55.61
2025-10-30 BUY 290 86.940 84.780 84.996 GBX 24,649 55.11
2025-10-29 BUY 522 85.000 87.510 87.259 GBX 45,549 54.94
2025-10-22 SELL -228 87.220 89.000 88.822 GBX -20,251 54.02 Loss of -7,934 on sale
2025-10-20 BUY 399 87.170 90.913 90.539 GBX 36,125 53.64
2025-10-15 BUY 456 76.980 78.170 78.051 GBX 35,591 53.29
2025-10-03 BUY 399 67.780 67.920 67.906 GBX 27,094 53.09
2025-10-02 BUY 57 65.860 67.280 67.138 GBX 3,827 53.01
2025-09-30 BUY 114 66.080 66.580 66.530 GBX 7,584 52.84
2025-09-26 BUY 114 65.550 65.940 65.901 GBX 7,513 52.69
2025-09-25 BUY 114 62.500 62.875 62.838 GBX 7,163 52.63
2025-09-18 BUY 60 62.630 62.640 62.639 GBX 3,758 52.57
2025-09-17 BUY 180 61.035 63.540 63.290 GBX 11,392 52.51
2025-07-17 SELL -120 57.790 59.750 59.554 GBX -7,146 52.35 Loss of -865 on sale
2025-07-11 SELL -480 56.910 57.725 57.643 GBX -27,669 52.22 Loss of -2,601 on sale
2025-07-02 BUY 3,300 53.170 53.660 53.611 GBX 176,916 52.14
2025-06-25 BUY 120 53.915 54.750 54.667 GBX 6,560 52.09
2025-06-20 BUY 529 51.610 51.840 51.817 GBX 27,411 52.07
2025-06-11 BUY 116 50.860 53.520 53.254 GBX 6,177 52.11
2025-06-10 BUY 116 53.070 54.280 54.159 GBX 6,282 52.10
2025-06-04 SELL -58 47.320 48.570 48.445 GBX -2,810 52.20 Profit of 218 on sale
2025-04-23 BUY 58 45.150 47.580 47.337 GBX 2,746 53.82
2025-04-10 SELL -464 35.230 40.400 39.883 GBX -18,506 55.14 Profit of 7,078 on sale
2025-04-08 SELL -58 34.280 41.000 40.328 GBX -2,339 55.56 Profit of 884 on sale
2025-04-07 SELL -58 39.200 40.760 40.604 GBX -2,355 55.76 Profit of 879 on sale
2025-04-04 SELL -290 41.220 44.990 44.613 GBX -12,938 55.93 Profit of 3,281 on sale
2025-04-01 BUY 693 47.150 49.610 49.364 GBX 34,209 56.12
2025-03-31 SELL -171 49.640 51.775 51.562 GBX -8,817 56.20 Profit of 793 on sale
2025-03-21 BUY 2,994 52.240 54.010 53.833 GBX 161,176 56.48
2025-03-14 SELL -752 51.020 53.640 53.378 GBX -40,140 56.76 Profit of 2,547 on sale
2025-03-07 SELL -94 55.670 57.040 56.903 GBX -5,349 56.98 Profit of 8 on sale
2025-03-04 SELL -47 55.340 56.300 56.204 GBX -2,642 57.04 Profit of 39 on sale
2025-02-25 BUY 94 53.530 54.880 54.745 GBX 5,146 57.25
2025-02-19 SELL -47 54.460 55.180 55.108 GBX -2,590 57.45 Profit of 110 on sale
2025-02-13 BUY 141 54.100 54.702 54.642 GBX 7,704 57.71
2025-02-12 BUY 47 53.640 54.110 54.063 GBX 2,541 57.79
2025-02-11 BUY 188 54.070 54.480 54.439 GBX 10,235 57.87
2024-12-30 SELL -1,634 61.600 63.570 63.373 GBX -103,551 58.48 Loss of -7,987 on sale
2024-11-18 SELL -765 57.350 60.000 59.735 GBX -45,697 53.11 Loss of -5,069 on sale
2024-11-08 SELL -51 65.000 67.440 67.196 GBX -3,427 51.53 Loss of -799 on sale
2024-10-21 SELL -51 50.770 51.260 51.211 GBX -2,612 0.00 Loss of -2,612 on sale
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-12-16	SELL	-58	91.780	90.165	90.327	GBX -5,239	60.54 Loss of -1,727 on sale
2025-12-15	BUY	116	92.530	90.010	90.262	GBX 10,470	60.39
2025-12-11	BUY	116	94.450	90.400	90.805	GBX 10,533	60.09
2025-12-04	BUY	1,160			93.790*		59.28
2025-12-02	BUY	870	93.325	89.440	89.829	GBX 78,151	58.97
2025-11-28	BUY	58	94.520	92.840	93.008	GBX 5,394	58.63
2025-11-26	BUY	174	94.130	91.730	91.970	GBX 16,003	58.28
2025-11-26	BUY	174	94.130	91.730	91.970	GBX 16,003	58.28
2025-11-25	BUY	290	95.135	91.660	92.008	GBX 26,682	58.11
2025-11-24	BUY	58	97.115	93.690	94.033	GBX 5,454	57.92
2025-11-20	SELL	-232	94.400	89.800	90.260	GBX -20,940	57.58 Loss of -7,583 on sale
2025-11-19	BUY	58	92.680	89.900	90.178	GBX 5,230	57.40
2025-11-18	BUY	348	90.680	87.560	87.872	GBX 30,579	57.24
2025-11-17	BUY	116	92.655	88.230	88.673	GBX 10,286	57.07
2025-11-14	BUY	58	90.850	86.930	87.322	GBX 5,065	56.89
2025-11-12	BUY	58	87.605	85.320	85.549	GBX 4,962	56.58
2025-11-10	BUY	58	85.570	82.235	82.569	GBX 4,789	56.27
2025-11-06	BUY	58	90.385	86.200	86.618	GBX 5,024	55.96
2025-11-04	BUY	58	87.125	83.010	83.422	GBX 4,838	55.61
2025-10-30	BUY	290	86.940	84.780	84.996	GBX 24,649	55.11
2025-10-29	BUY	522	85.000	87.510	87.259	GBX 45,549	54.94
2025-10-22	SELL	-228	87.220	89.000	88.822	GBX -20,251	54.02 Loss of -7,934 on sale
2025-10-20	BUY	399	87.170	90.913	90.539	GBX 36,125	53.64
2025-10-15	BUY	456	76.980	78.170	78.051	GBX 35,591	53.29
2025-10-03	BUY	399	67.780	67.920	67.906	GBX 27,094	53.09
2025-10-02	BUY	57	65.860	67.280	67.138	GBX 3,827	53.01
2025-09-30	BUY	114	66.080	66.580	66.530	GBX 7,584	52.84
2025-09-26	BUY	114	65.550	65.940	65.901	GBX 7,513	52.69
2025-09-25	BUY	114	62.500	62.875	62.838	GBX 7,163	52.63
2025-09-18	BUY	60	62.630	62.640	62.639	GBX 3,758	52.57
2025-09-17	BUY	180	61.035	63.540	63.290	GBX 11,392	52.51
2025-07-17	SELL	-120	57.790	59.750	59.554	GBX -7,146	52.35 Loss of -865 on sale
2025-07-11	SELL	-480	56.910	57.725	57.643	GBX -27,669	52.22 Loss of -2,601 on sale
2025-07-02	BUY	3,300	53.170	53.660	53.611	GBX 176,916	52.14
2025-06-25	BUY	120	53.915	54.750	54.667	GBX 6,560	52.09
2025-06-20	BUY	529	51.610	51.840	51.817	GBX 27,411	52.07
2025-06-11	BUY	116	50.860	53.520	53.254	GBX 6,177	52.11
2025-06-10	BUY	116	53.070	54.280	54.159	GBX 6,282	52.10
2025-06-04	SELL	-58	47.320	48.570	48.445	GBX -2,810	52.20 Profit of 218 on sale
2025-04-23	BUY	58	45.150	47.580	47.337	GBX 2,746	53.82
2025-04-10	SELL	-464	35.230	40.400	39.883	GBX -18,506	55.14 Profit of 7,078 on sale
2025-04-08	SELL	-58	34.280	41.000	40.328	GBX -2,339	55.56 Profit of 884 on sale
2025-04-07	SELL	-58	39.200	40.760	40.604	GBX -2,355	55.76 Profit of 879 on sale
2025-04-04	SELL	-290	41.220	44.990	44.613	GBX -12,938	55.93 Profit of 3,281 on sale
2025-04-01	BUY	693	47.150	49.610	49.364	GBX 34,209	56.12
2025-03-31	SELL	-171	49.640	51.775	51.562	GBX -8,817	56.20 Profit of 793 on sale
2025-03-21	BUY	2,994	52.240	54.010	53.833	GBX 161,176	56.48
2025-03-14	SELL	-752	51.020	53.640	53.378	GBX -40,140	56.76 Profit of 2,547 on sale
2025-03-07	SELL	-94	55.670	57.040	56.903	GBX -5,349	56.98 Profit of 8 on sale
2025-03-04	SELL	-47	55.340	56.300	56.204	GBX -2,642	57.04 Profit of 39 on sale
2025-02-25	BUY	94	53.530	54.880	54.745	GBX 5,146	57.25
2025-02-19	SELL	-47	54.460	55.180	55.108	GBX -2,590	57.45 Profit of 110 on sale
2025-02-13	BUY	141	54.100	54.702	54.642	GBX 7,704	57.71
2025-02-12	BUY	47	53.640	54.110	54.063	GBX 2,541	57.79
2025-02-11	BUY	188	54.070	54.480	54.439	GBX 10,235	57.87
2024-12-30	SELL	-1,634	61.600	63.570	63.373	GBX -103,551	58.48 Loss of -7,987 on sale
2024-11-18	SELL	-765	57.350	60.000	59.735	GBX -45,697	53.11 Loss of -5,069 on sale
2024-11-08	SELL	-51	65.000	67.440	67.196	GBX -3,427	51.53 Loss of -799 on sale
2024-10-21	SELL	-51	50.770	51.260	51.211	GBX -2,612	0.00 Loss of -2,612 on sale

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of IRON

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	42,043	0	161,060	26.1%
2025-09-18	59,541	0	240,152	24.8%
2025-09-17	77,832	0	216,638	35.9%
2025-09-16	62,100	0	72,556	85.6%
2025-09-15	59,801	752	135,681	44.1%
2025-09-12	50,465	0	58,447	86.3%
2025-09-11	32,597	0	37,435	87.1%
2025-09-10	64,174	169	101,286	63.4%
2025-09-09	164,861	0	263,035	62.7%
2025-09-08	158,200	4,201	349,850	45.2%
2025-09-05	34,558	0	43,863	78.8%
2025-09-04	60,889	0	88,197	69.0%
2025-09-03	72,780	0	115,523	63.0%
2025-09-02	64,231	0	122,075	52.6%
2025-08-29	37,236	0	52,940	70.3%
2025-08-28	23,628	0	63,708	37.1%
2025-08-27	20,780	320	49,538	41.9%
2025-08-26	28,218	0	75,891	37.2%
2025-08-25	20,773	60	45,076	46.1%
2025-08-22	44,601	0	108,373	41.2%
2025-08-21	45,805	200	78,260	58.5%
2025-08-20	48,800	0	91,536	53.3%
2025-08-19	52,943	0	71,148	74.4%
2025-08-18	72,883	0	123,735	58.9%
2025-08-15	43,075	1,500	109,694	39.3%
2025-08-14	79,414	0	177,354	44.8%
2025-08-13	84,173	400	308,032	27.3%
2025-08-12	64,642	0	154,504	41.8%
2025-08-11	88,386	0	131,952	67.0%
2025-08-08	89,835	0	103,971	86.4%
2025-08-07	83,566	0	106,403	78.5%
2025-08-06	71,182	34	151,053	47.1%
2025-08-05	53,474	30	121,973	43.8%
2025-08-04	52,770	0	120,311	43.9%
2025-08-01	111,260	2,084	177,997	62.5%
2025-07-31	87,913	265	142,345	61.8%
2025-07-30	84,405	65	126,564	66.7%
2025-07-29	69,025	215	77,683	88.9%
2025-07-28	77,300	0	104,064	74.3%
2025-07-25	75,307	4	104,658	72.0%
2025-07-24	99,994	176	207,557	48.2%
2025-07-23	115,576	0	199,628	57.9%
2025-07-22	74,583	400	139,437	53.5%
2025-07-21	157,158	70	298,019	52.7%
2025-07-18	112,275	565	294,434	38.1%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Stock Name / Fund	iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Issuer	Blackrock
ETF Ticker	BTEE(USD) LSE
ETF Ticker	BTEE.L(GBP) LSE